Evidence map›Paper›PMID 21746877›Full record

ArticleMolecular and cellular biology2011

Hypoxia-inducible factor 1 is activated by dysregulated cyclin E during mammary epithelial morphogenesis.

Tanushri Sengupta, Gathi Abraham, Yanfei Xu, Bruce E Clurman, Alex C Minella

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02160730 (Treatment of Pituitary Cushing Disease With a Selective CDK Inhibitor, R-roscovitine), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02160730 phase2terminatednot on this mapstarted 2014, after this paper: background citation

Treatment of Pituitary Cushing Disease With a Selective CDK Inhibitor, R-roscovitine

TypeinterventionalSponsorShlomo Melmed, MDRan2014 to 2018Enrolled4ConditionsCushings DiseaseArmsR-roscovitine
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  8. Article
  9. Regulation of cell proliferation by hypoxia-inducible factors.American journal of physiology. Cell physiology · 2015
    Review
  10. Cell cycle progression in response to oxygen levels.Cellular and molecular life sciences : CMLS · 2014
    Review
  11. Article
  12. Opiorphin is a master regulator of the hypoxic response in corporal smooth muscle cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2014
    Article
  13. Article
  14. Article
  15. An integrated view of cyclin E function and regulation.Cell cycle (Georgetown, Tex.) · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Tanushri SenguptaDepartment of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
Gathi Abraham
Yanfei Xu
Bruce E Clurman
Alex C Minella
Northwestern University · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZA

Funding

Normal and Neoplastic Regulation of Cyclin ER01CA102742 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CLURMAN, BRUCE E · 2003 to 2013
$3.8M
The role of cyclin E deregulation in breast tumorigenesisK22CA130984 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MINELLA, ALEXANDER C · 2008 to 2010
$463k
NCI NIH HHS K22 CA130984NCI NIH HHS K22CA130984NCI NIH HHS R01 CA102742NCI NIH HHS R01CA102742
6 · The paper itself

Abstract

Increased cyclin E expression has been identified in human tumors of diverse histologies, and in studies of primary breast cancers, high cyclin E is associated with poor prognosis. We have studied dysregulated cyclin E in epithelial tissues using organotypic cultures of human mammary epithelial cells and a murine model. We unexpectedly discovered that dysregulated cyclin E impairs normal acinar morphogenesis in vitro, and this is associated with the induction of p21(Cip1), p27(Kip1), and cellular senescence. Cyclin E-induced morphogenesis arrest is dependent upon hypoxia-inducible factor 1α (HIF-1α), which itself is induced by high cyclin E both in cultured mammary acini and in mammary epithelial tissues in a mouse model of deregulated cyclin E expression. We next determined that E2F activity directly regulates and is required for induction of HIF1A by cyclin E. Additionally, we found that cyclin E deregulation in mammary acini decreases, in an E2F-independent manner, expression of the EGLN1 prolyl hydroxylase that regulates HIF-1α degradation within the VHL ubiquitin ligase pathway. Together, our findings reveal a direct link between cyclin E and HIF-1 activities in mammary epithelial cells and implicate HIF-1 as a mediator of proliferation-independent phenotypes associated with high cyclin E expression in some human breast cancers.

Indexed as

Cyclin EAnimalsBreast NeoplasmsCell CycleCell LineCellular SenescenceChromatin ImmunoprecipitationCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27E2F Transcription FactorsFemaleHEK293 CellsHumansHypoxia-Inducible Factor 1, alpha SubunitMammary Glands, AnimalMammary Glands, HumanCdkn1a protein, mouseCdkn1b protein, mouseCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27Cyclin EE2F Transcription FactorsHypoxia-Inducible Factor 1, alpha SubunitRNA, Small Interfering

Identifiers

PMID21746877
PMCPMC3165725
OpenAlexW1992247552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.